Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Nucleic Acid-Based Drug Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 siRNA
1.2.3 Antisense Oligonucleotides
1.3 Market by Application
1.3.1 Global Small Nucleic Acid-Based Drug Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Nucleic Acid-Based Drug Market Perspective (2024-2034)
2.2 Small Nucleic Acid-Based Drug Growth Trends by Region
2.2.1 Global Small Nucleic Acid-Based Drug Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Small Nucleic Acid-Based Drug Historic Market Size by Region (2024-2024)
2.2.3 Small Nucleic Acid-Based Drug Forecasted Market Size by Region (2024-2034)
2.3 Small Nucleic Acid-Based Drug Market Dynamics
2.3.1 Small Nucleic Acid-Based Drug Industry Trends
2.3.2 Small Nucleic Acid-Based Drug Market Drivers
2.3.3 Small Nucleic Acid-Based Drug Market Challenges
2.3.4 Small Nucleic Acid-Based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Nucleic Acid-Based Drug Players by Revenue
3.1.1 Global Top Small Nucleic Acid-Based Drug Players by Revenue (2024-2024)
3.1.2 Global Small Nucleic Acid-Based Drug Revenue Market Share by Players (2024-2024)
3.2 Global Small Nucleic Acid-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Nucleic Acid-Based Drug Revenue
3.4 Global Small Nucleic Acid-Based Drug Market Concentration Ratio
3.4.1 Global Small Nucleic Acid-Based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Nucleic Acid-Based Drug Revenue in 2022
3.5 Small Nucleic Acid-Based Drug Key Players Head office and Area Served
3.6 Key Players Small Nucleic Acid-Based Drug Product Solution and Service
3.7 Date of Enter into Small Nucleic Acid-Based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Nucleic Acid-Based Drug Breakdown Data by Type
4.1 Global Small Nucleic Acid-Based Drug Historic Market Size by Type (2024-2024)
4.2 Global Small Nucleic Acid-Based Drug Forecasted Market Size by Type (2024-2034)
5 Small Nucleic Acid-Based Drug Breakdown Data by Application
5.1 Global Small Nucleic Acid-Based Drug Historic Market Size by Application (2024-2024)
5.2 Global Small Nucleic Acid-Based Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Small Nucleic Acid-Based Drug Market Size (2024-2034)
6.2 North America Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Small Nucleic Acid-Based Drug Market Size by Country (2024-2024)
6.4 North America Small Nucleic Acid-Based Drug Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Nucleic Acid-Based Drug Market Size (2024-2034)
7.2 Europe Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Small Nucleic Acid-Based Drug Market Size by Country (2024-2024)
7.4 Europe Small Nucleic Acid-Based Drug Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Nucleic Acid-Based Drug Market Size (2024-2034)
8.2 Asia-Pacific Small Nucleic Acid-Based Drug Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2024-2024)
8.4 Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Nucleic Acid-Based Drug Market Size (2024-2034)
9.2 Latin America Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Small Nucleic Acid-Based Drug Market Size by Country (2024-2024)
9.4 Latin America Small Nucleic Acid-Based Drug Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Nucleic Acid-Based Drug Market Size (2024-2034)
10.2 Middle East & Africa Small Nucleic Acid-Based Drug Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2024-2024)
10.4 Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Small Nucleic Acid-Based Drug Introduction
11.1.4 Biogen Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.1.5 Biogen Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Small Nucleic Acid-Based Drug Introduction
11.2.4 Pfizer Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.2.5 Pfizer Recent Development
11.3 Jazz
11.3.1 Jazz Company Detail
11.3.2 Jazz Business Overview
11.3.3 Jazz Small Nucleic Acid-Based Drug Introduction
11.3.4 Jazz Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.3.5 Jazz Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Small Nucleic Acid-Based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam
11.5.1 Alnylam Company Detail
11.5.2 Alnylam Business Overview
11.5.3 Alnylam Small Nucleic Acid-Based Drug Introduction
11.5.4 Alnylam Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.5.5 Alnylam Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Small Nucleic Acid-Based Drug Introduction
11.6.4 Novartis Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.6.5 Novartis Recent Development
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Detail
11.7.2 Nippon Shinyaku Business Overview
11.7.3 Nippon Shinyaku Small Nucleic Acid-Based Drug Introduction
11.7.4 Nippon Shinyaku Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.7.5 Nippon Shinyaku Recent Development
11.8 Swedish Orphan Biovitrum
11.8.1 Swedish Orphan Biovitrum Company Detail
11.8.2 Swedish Orphan Biovitrum Business Overview
11.8.3 Swedish Orphan Biovitrum Small Nucleic Acid-Based Drug Introduction
11.8.4 Swedish Orphan Biovitrum Revenue in Small Nucleic Acid-Based Drug Business (2024-2024)
11.8.5 Swedish Orphan Biovitrum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Small Nucleic Acid-Based Drug Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of siRNA
Table 3. Key Players of Antisense Oligonucleotides
Table 4. Global Small Nucleic Acid-Based Drug Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 5. Global Small Nucleic Acid-Based Drug Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Small Nucleic Acid-Based Drug Market Size by Region (2024-2024) & (US$ Million)
Table 7. Global Small Nucleic Acid-Based Drug Market Share by Region (2024-2024)
Table 8. Global Small Nucleic Acid-Based Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Small Nucleic Acid-Based Drug Market Share by Region (2024-2034)
Table 10. Small Nucleic Acid-Based Drug Market Trends
Table 11. Small Nucleic Acid-Based Drug Market Drivers
Table 12. Small Nucleic Acid-Based Drug Market Challenges
Table 13. Small Nucleic Acid-Based Drug Market Restraints
Table 14. Global Small Nucleic Acid-Based Drug Revenue by Players (2024-2024) & (US$ Million)
Table 15. Global Small Nucleic Acid-Based Drug Market Share by Players (2024-2024)
Table 16. Global Top Small Nucleic Acid-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid-Based Drug as of 2022)
Table 17. Ranking of Global Top Small Nucleic Acid-Based Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Small Nucleic Acid-Based Drug Revenue (CR5 and HHI) & (2024-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Small Nucleic Acid-Based Drug Product Solution and Service
Table 21. Date of Enter into Small Nucleic Acid-Based Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Nucleic Acid-Based Drug Market Size by Type (2024-2024) & (US$ Million)
Table 24. Global Small Nucleic Acid-Based Drug Revenue Market Share by Type (2024-2024)
Table 25. Global Small Nucleic Acid-Based Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Small Nucleic Acid-Based Drug Revenue Market Share by Type (2024-2034)
Table 27. Global Small Nucleic Acid-Based Drug Market Size by Application (2024-2024) & (US$ Million)
Table 28. Global Small Nucleic Acid-Based Drug Revenue Market Share by Application (2024-2024)
Table 29. Global Small Nucleic Acid-Based Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Small Nucleic Acid-Based Drug Revenue Market Share by Application (2024-2034)
Table 31. North America Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 32. North America Small Nucleic Acid-Based Drug Market Size by Country (2024-2024) & (US$ Million)
Table 33. North America Small Nucleic Acid-Based Drug Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 35. Europe Small Nucleic Acid-Based Drug Market Size by Country (2024-2024) & (US$ Million)
Table 36. Europe Small Nucleic Acid-Based Drug Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Small Nucleic Acid-Based Drug Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2024-2024) & (US$ Million)
Table 39. Asia-Pacific Small Nucleic Acid-Based Drug Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 41. Latin America Small Nucleic Acid-Based Drug Market Size by Country (2024-2024) & (US$ Million)
Table 42. Latin America Small Nucleic Acid-Based Drug Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Small Nucleic Acid-Based Drug Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 44. Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2024-2024) & (US$ Million)
Table 45. Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Country (2024-2034) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Small Nucleic Acid-Based Drug Product
Table 49. Biogen Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Small Nucleic Acid-Based Drug Product
Table 54. Pfizer Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Jazz Company Detail
Table 57. Jazz Business Overview
Table 58. Jazz Small Nucleic Acid-Based Drug Product
Table 59. Jazz Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 60. Jazz Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Small Nucleic Acid-Based Drug Product
Table 64. Sarepta Therapeutics Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Company Detail
Table 67. Alnylam Business Overview
Table 68. Alnylam Small Nucleic Acid-Based Drug Product
Table 69. Alnylam Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 70. Alnylam Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Small Nucleic Acid-Based Drug Product
Table 74. Novartis Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Nippon Shinyaku Company Detail
Table 77. Nippon Shinyaku Business Overview
Table 78. Nippon Shinyaku Small Nucleic Acid-Based Drug Product
Table 79. Nippon Shinyaku Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 80. Nippon Shinyaku Recent Development
Table 81. Swedish Orphan Biovitrum Company Detail
Table 82. Swedish Orphan Biovitrum Business Overview
Table 83. Swedish Orphan Biovitrum Small Nucleic Acid-Based Drug Product
Table 84. Swedish Orphan Biovitrum Revenue in Small Nucleic Acid-Based Drug Business (2024-2024) & (US$ Million)
Table 85. Swedish Orphan Biovitrum Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Nucleic Acid-Based Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Small Nucleic Acid-Based Drug Market Share by Type: 2022 VS 2034
Figure 3. siRNA Features
Figure 4. Antisense Oligonucleotides Features
Figure 5. Global Small Nucleic Acid-Based Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Small Nucleic Acid-Based Drug Market Share by Application: 2022 VS 2034
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Small Nucleic Acid-Based Drug Report Years Considered
Figure 11. Global Small Nucleic Acid-Based Drug Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 12. Global Small Nucleic Acid-Based Drug Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Small Nucleic Acid-Based Drug Market Share by Region: 2022 VS 2034
Figure 14. Global Small Nucleic Acid-Based Drug Market Share by Players in 2022
Figure 15. Global Top Small Nucleic Acid-Based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid-Based Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Small Nucleic Acid-Based Drug Revenue in 2022
Figure 17. North America Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 18. North America Small Nucleic Acid-Based Drug Market Share by Country (2024-2034)
Figure 19. United States Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Canada Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Small Nucleic Acid-Based Drug Market Share by Country (2024-2034)
Figure 23. Germany Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. France Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. U.K. Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Italy Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Russia Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Nordic Countries Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Small Nucleic Acid-Based Drug Market Share by Region (2024-2034)
Figure 31. China Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Japan Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. South Korea Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Southeast Asia Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. India Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Australia Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Small Nucleic Acid-Based Drug Market Share by Country (2024-2034)
Figure 39. Mexico Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Brazil Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Small Nucleic Acid-Based Drug Market Share by Country (2024-2034)
Figure 43. Turkey Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Saudi Arabia Small Nucleic Acid-Based Drug Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 46. Pfizer Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 47. Jazz Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 49. Alnylam Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 50. Novartis Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 51. Nippon Shinyaku Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 52. Swedish Orphan Biovitrum Revenue Growth Rate in Small Nucleic Acid-Based Drug Business (2024-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed